Latest Lion Point Capital, LP Stock Portfolio
$178Million
Equity Portfolio Value
Last Reported on: 15 May, 2024
About Lion Point Capital, LP and it’s 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Lion Point Capital, LP reported an equity portfolio of $179 Millions as of 31 Mar, 2024.
The top stock holdings of Lion Point Capital, LP are MRNS, ARDX, MIST. The fund has invested 10.7% of it's portfolio in MARINUS PHARMACEUTICALS INC and 4.3% of portfolio in ARDELYX INC.
The fund managers got completely rid off HARPOON THERAPEUTICS INC (HARP), CYMABAY THERAPEUTICS INC (CBAY) and AMYLYX PHARMACEUTICALS INC (AMLX) stocks. They significantly reduced their stock positions in SEMTECH CORP (SMTC), BATTALION OIL CORPORATION (BATL) and ARDELYX INC (ARDX). Lion Point Capital, LP opened new stock positions in GERON CORP (GERN), NEUROCRINE BIOSCIENCES INC (NBIX) and JASPER THERAPEUTICS INC (JSPR). The fund showed a lot of confidence in some stocks as they added substantially to SYNDAX PHARMACEUTICALS INC (SNDX), BLUEBIRD BIO INC (BLUE) and FENNEC PHARMACEUTICALS INC (FENC).
The top stock holdings of Lion Point Capital, LP are MRNS, ARDX, MIST. The fund has invested 10.7% of it's portfolio in MARINUS PHARMACEUTICALS INC and 4.3% of portfolio in ARDELYX INC.
The fund managers got completely rid off HARPOON THERAPEUTICS INC (HARP), CYMABAY THERAPEUTICS INC (CBAY) and AMYLYX PHARMACEUTICALS INC (AMLX) stocks. They significantly reduced their stock positions in SEMTECH CORP (SMTC), BATTALION OIL CORPORATION (BATL) and ARDELYX INC (ARDX). Lion Point Capital, LP opened new stock positions in GERON CORP (GERN), NEUROCRINE BIOSCIENCES INC (NBIX) and JASPER THERAPEUTICS INC (JSPR). The fund showed a lot of confidence in some stocks as they added substantially to SYNDAX PHARMACEUTICALS INC (SNDX), BLUEBIRD BIO INC (BLUE) and FENNEC PHARMACEUTICALS INC (FENC).
New Buys
| Ticker | $ Bought |
|---|---|
| GERON CORP | 1,980,000 |
| NEUROCRINE BIOSCIENCES INC | 1,034,400 |
| JASPER THERAPEUTICS INC | 939,520 |
| MINERALYS THERAPEUTICS INC | 774,600 |
| REGENXBIO INC | 684,775 |
| SPRUCE BIOSCIENCES INC | 58,943 |
New stocks bought by Lion Point Capital, LP
Additions
| Ticker | % Inc. |
|---|---|
| SYNDAX PHARMACEUTICALS INC | 88.41 |
| BLUEBIRD BIO INC | 59.67 |
| FENNEC PHARMACEUTICALS INC | 54.55 |
| MILESTONE PHARMACEUTICALS IN | 39.39 |
| AVADEL PHARMACEUTICALS PLC | 3.12 |
Additions to existing portfolio by Lion Point Capital, LP
Reductions
| Ticker | % Reduced |
|---|---|
| SEMTECH CORP | -100 |
| BATTALION OIL CORPORATION | -91.03 |
| ARDELYX INC | -9.12 |
| MARINUS PHARMACEUTICALS INC | -0.71 |
Lion Point Capital, LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| HARPOON THERAPEUTICS INC | -2,602,590 |
| ACLARIS THERAPEUTICS INC | -121,693 |
| CYMABAY THERAPEUTICS INC | -1,946,880 |
| AADI BIOSCIENCE INC | -166,494 |
| AMYLYX PHARMACEUTICALS INC | -206,080 |
Lion Point Capital, LP got rid off the above stocks
Current Stock Holdings of Lion Point Capital, LP
Last Reported on: 15 May, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options |
|---|---|---|---|---|---|---|---|
| AADI | AADI BIOSCIENCE INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| ACRS | ACLARIS THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| AMLX | AMYLYX PHARMACEUTICALS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| ARDX | ARDELYX INC | 4.27 | 1,046,670 | 7,640,670 | REDUCED | -9.12 | |
| AVDL | AVADEL PHARMACEUTICALS PLC | 0.78 | 82,500 | 1,393,420 | ADDED | 3.12 | |
| BATL | BATTALION OIL CORPORATION | 0.06 | 19,926 | 112,781 | REDUCED | -91.03 | |
| BFI | BURGERFI INTERNATIONAL INC | 0.89 | 2,745,940 | 1,585,780 | UNCHANGED | 0.00 | |
| BFI | BURGERFI INTERNATIONAL INC | 0.04 | 2,083,440 | 81,254 | UNCHANGED | 0.00 | |
| BLUE | BLUEBIRD BIO INC | 0.61 | 848,256 | 1,085,770 | ADDED | 59.67 | |
| CBAY | CYMABAY THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| FENC | FENNEC PHARMACEUTICALS INC | 1.06 | 170,000 | 1,890,400 | ADDED | 54.55 | |
| GERN | GERON CORP | 1.11 | 600,000 | 1,980,000 | NEW | ||
| GOOG | ALPHABET INC | 0.01 | 100 | 15,226 | UNCHANGED | 0.00 | |
| HARP | HARPOON THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| HUMA | HUMACYTE INC | 0.41 | 235,000 | 730,850 | UNCHANGED | 0.00 | |
| INSM | INSMED INC | 1.07 | 70,335 | 1,908,190 | UNCHANGED | 0.00 | |
| JSPR | JASPER THERAPEUTICS INC | 0.52 | 32,000 | 939,520 | NEW | ||
| KNSA | KINIKSA PHARMACEUTICALS LTD | 1.44 | 130,691 | 2,578,530 | UNCHANGED | 0.00 | |
| LUMO | LUMOS PHARMA INC | 0.14 | 90,794 | 256,039 | UNCHANGED | 0.00 | |
| MCRB | SERES THERAPEUTICS INC | 0.15 | 340,761 | 263,783 | UNCHANGED | 0.00 | |
| MIST | MILESTONE PHARMACEUTICALS IN | 2.30 | 2,300,210 | 4,117,370 | ADDED | 39.39 | |
| MRNS | MARINUS PHARMACEUTICALS INC | 10.70 | 2,119,140 | 19,157,000 | REDUCED | -0.71 | |
| MSFT | MICROSOFT CORP | 0.02 | 100 | 42,072 | UNCHANGED | 0.00 | |
| NBIX | NEUROCRINE BIOSCIENCES INC | 0.58 | 7,500 | 1,034,400 | NEW | ||
| NFYS | ENPHYS ACQUISITION CORP | 0.47 | 78,125 | 845,313 | UNCHANGED | 0.00 | |
| REPL | REPLIMUNE GROUP INC | 0.19 | 42,500 | 347,225 | UNCHANGED | 0.00 | |
| RGNX | REGENXBIO INC | 0.38 | 32,500 | 684,775 | NEW | ||
| SMTC | SEMTECH CORP | 0.00 | 14.00 | 385 | REDUCED | -100 | |
| SNDX | SYNDAX PHARMACEUTICALS INC | 0.86 | 65,000 | 1,547,000 | ADDED | 88.41 | |
| SPRB | SPRUCE BIOSCIENCES INC | 0.03 | 75,000 | 58,943 | NEW | ||
| TVTX | TRAVERE THERAPEUTICS INC | 0.35 | 1,000,000 | 629,500 | UNCHANGED | 0.00 | |
| TVTX | TRAVERE THERAPEUTICS INC | 0.34 | 78,000 | 601,380 | UNCHANGED | 0.00 | |
| MINERALYS THERAPEUTICS INC | 0.43 | 60,000 | 774,600 | NEW |